- Peripheral arterial disease (PAD) is a common circulatory problem where narrowed arteries reduce blood flow to the limbs, particularly affecting the lower extremities. PAD treatments include medications, angioplasty, stenting, and surgical interventions
- The demand for PAD treatments is largely driven by the growing prevalence of risk factors such as aging, diabetes, hypertension, and smoking. With the aging global population and increasing chronic conditions, the need for effective PAD management continues to rise
- North America is a dominant region for the PAD market, driven by advanced healthcare infrastructure, high awareness of cardiovascular diseases, and a significant population suffering from risk factors such as diabetes and hypertension. The region is also a leader in adopting new technologies and treatment methods for PAD
- For instance, in the United States, the prevalence of Peripheral Arterial Disease (PAD) is rising, particularly among individuals over the age of 60, due to the aging population and increasing rates of diabetes and hypertension.
- Globally, PAD treatments are considered among the most crucial interventions in cardiovascular care, with a growing focus on minimally invasive techniques such as endovascular surgery, which ensure faster recovery times and better outcomes for patients
